Pharmacotherapy and Intensive Treatment of Drug Abuse - 1
Launched by UNIVERSITY OF KANSAS · Sep 20, 1999
Trial Information
Current as of May 11, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- • Please contact site for information.
About University Of Kansas
The University of Kansas is a prestigious research institution committed to advancing knowledge and improving health outcomes through innovative clinical trials. As a sponsor, the university leverages its extensive academic resources and expertise to conduct rigorous research across various medical disciplines. With a focus on collaboration and scientific integrity, the University of Kansas aims to translate research findings into effective treatments and interventions, ultimately enhancing patient care and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kansas City, Missouri, United States
Patients applied
Trial Officials
William Haning, M.D.
Principal Investigator
University of Kansas
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials